Powered by Clearbit
AngioDynamics Inc (NMS: ANGO)+ to Company Analysis List
Address: 14 Plaza Drive,Latham, NY 12110 United States  |  Phone: 518 795-1400  |  Company Website: www.angiodynamics.com

Incorporated: 1988 , NY, United States

Reincorporated: 1992 , DE, United States

Auditor: DELOITTE & TOUCHE LLP

Legal Counsel: Davies Ward Phillips & Vineberg LLP

Transfer Agent: Registrar and Transfer Company, Cranford, NJ

Country:  United States

Industry: Medical Supplies (ICB 20102015)

Industry: Surgical and medical instruments (SIC 3841)

Industry: Surgical and Medical Instrument Manufacturing (NAICS 339112)

Number of Employees: 815 (Approximate Full-Time as of 05/31/2023)

Number of Shareholders: 169 (record) (as of 08/02/2023)

Market Cap: 222,705,800

Revenue: 324,008,000

Net Income: -192,367,000

EPS Basic: -4.78    EPS Diluted: -4.78

Synopsis Highlights History Business Property Subsidiaries Long term debt Capital stock Earnings estimates Business segments
Download  Printer Friendly My Mergent Tools
Company Analysis List (0/500)
No company added to the Company Analysis List
Executive List (0/500)
No executive added to the Executive List
Mergent Private Company List (0/500)
No company added to the Mergent Private Company List
Company Alerts (0)
No alerts added to Alerts
Executive Alerts (0)
No alerts added to Executive Alerts

Business Summary

AngioDynamics designs, manufactures and sells a range of medical, surgical and diagnostic devices used by healthcare provider. Co.'s product offerings fall within Med Tech and Med Device segments. Co.'s technology products include auryon and thrombectomy platformwhich includes AngioVac, AlphaVac and thrombolytics atheters, and nanoknife. Co.'s Peripheral Products include angiographic products and accessories, drainage products, and micro access kits. Co. provides a variety of dialysis catheters, including: BioFlo DuraMax, which is a dialysis catheter with Endexo Technology; and DuraMax, which is a stepped-tip catheter.







Pricing Summary


Time Period


 Yesterday5 Days30 Days
Close5.565.726.52
Volume488,056.00491,740.00288,521.00
 
52 Week High/Low : 9.94 - 5.27
% Price Change (100 Days) : -5.28
200-Day Moving Avg. : 6.16


Company News







Corporate Events
















Key Executives

Age 
Chairman61
 
AgeSalary
President,Chief Executive Officer58736,154
 
AgeSalary
Executive Vice President,Chief Financial Officer,General Counsel48409,692
 
AgeSalary
Senior Vice President59360,529
 
AgeSalary
Senior Vice President,Division Officer51324,146
 

Key Financials

(In USD as of 02/29/2024)

Income Statement
Revenue324m
Net Income-192m
EPS from Continuing Operations-4.78
EPS - Net Income - Diluted-4.78
Revenue per Share8.05
Balance Sheet
Total Assets325m
Total Liabilities106m
Shareholders' Equity219m
Total Assets per Share8.04
Net Assets per Share5.41
Cash Flows
Cash from Operations-17m
Cash from Investing125m
Cash from Financing-59m
Capital Expenditures3m
Cash Flow per Share-0.43